Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study).

Julkaisu

Reference

Buvat J, Montorsi F, Maggi M, et al. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). J Sex Med 2011:8(1):284-293.

Julkaisutiedot

Julkaisutyyppi: Alkuperäisartikkeli.
Kansainvälinen.
Kieli: Englanti.

Teksti/tiivistelmä: https://www.ncbi.nlm.nih.gov/pubmed/20704642

Publication data

Publication type: Original scientific article.
International.
In English.

Text/summary: https://www.ncbi.nlm.nih.gov/pubmed/20704642

Tekijät

Contributors

Tampereen yliopisto

Lääketieteen laitos/urologia
- Antti Kaipia

University of Tampere

Medical School/Department of Urology
- Antti Kaipia

Tampereen yliopistollinen sairaala

Kirurgian vastuualue
- Antti Kaipia

Tampere University Hospital

Julkaisutietokanta 28.9.2011

Publications Data Base 28.9.2011